Table 1.
Characteristics of complete cohort and study patients
| Complete cohort | Study patients | P valuea | |
|---|---|---|---|
| Patients, N | 85 | 37 | |
| Female sex, N (%) | 43 (50.6) | 16 (43.2) | NS |
| Age at diagnosis <4 years, N (%) | 35 (41.2) | 15 (40.5) | NS |
| Age at diagnosis (years) | |||
| Median (range) | 4.8 (0.2–13.7) | 4.8 (0.2–12.2) | NS |
| Age at time of study (years) | |||
| Median (range) | 19.8 (11.6–28.4) | 19.0 (11.6–26.8) | NS |
| Years since anthracycline treatment | |||
| Median (range) | 13.9 (10.6–18.8) | 13.3 (10.6–18.3) | NS |
| Anthracycline dose | |||
| 180 mg/m2, N (%) | 51 (60) | 19 (51.4) | NS |
| 240 mg/m2, N (%) | 34 (40) | 18 (48.6) | NS |
NS non significant
aTest type: nonparametric test, two independent samples (Mann–Whitney U)